Device Cvs/Pts

Dominant Flex

Payments companies reported to CMS as associated with Dominant Flex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,705associated payments (2023-2025)
30clinicians with associated payments
1company reporting

By year

2024 $1,705

Payments reported as associated with Dominant Flex, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,583
Surgery $53.98
Acute Care (Nurse Practitioner) $27.44
Surgical $20.24
Pulmonary Disease $10.12
Physician Assistant $10.12

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dominant Flex

These are the largest totals companies reported as associated with Dominant Flex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Kevin Lobdell Charlotte, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $518.26
Stephen Cassivi Rochester, MN Thoracic Surgery (Cardiothoracic Vascular Surgery) $289.79
Daniel Engelman Springfield, MA Thoracic Surgery (Cardiothoracic Vascular Surgery) $289.77
Carmelo Milano Lumberton, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $228.48
Joseph Wilson Rancho Mirage, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $45.90
Daniel Logsdon Rancho Mirage, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $45.89
David Seaman Louisburg, NC Surgery $33.74
John Maurice Orange, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $23.40
Brytni Moore Dallas, TX Acute Care (Nurse Practitioner) $17.32
Todd Demmy Buffalo, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $10.12

Prescribed Dominant Flex?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.